Altered surface expression of CD11 and Leu 8 during human basophil degranulation

B S Bochner1, S A Sterbinsky

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224.

Insights

Human basophil activation by secretagogues causes changes in surface adhesion molecules like CD11b and Leu 8. These phenotypic shifts, including CD11b up-regulation, can occur independently of degranulation.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Human basophils play a crucial role in allergic responses and inflammation.
  • Understanding basophil activation and degranulation is key to developing targeted therapies.

Purpose of the Study:

  • To investigate changes in surface antigen (Ag) expression and viability during human basophil degranulation.
  • To analyze the relationship between degranulation, histamine release, and alterations in adhesion molecule expression.

Main Methods:

  • Utilized immunofluorescence and flow cytometry to assess surface Ag expression and cell viability.
  • Stimulated human basophils with anti-IgE, FMLP, and calcium ionophore A23187.
  • Measured histamine release, CD11b, CD11c, CD11a, and Leu 8 expression, and propidium iodide exclusion.

Main Results:

  • Secretagogue treatment induced histamine release and increased CD11b expression, while decreasing Leu 8 expression.
  • Degranulation did not significantly impact basophil viability or scatter characteristics.
  • Changes in CD11b and Leu 8 expression occurred even without degranulation, suggesting activation pathways independent of histamine release.

Conclusions:

  • Activation of human basophils in vitro leads to phenotypic changes, including altered surface expression of adhesion molecules.
  • These findings suggest that changes in adhesion-related functions may precede or accompany basophil degranulation in vivo.

Related Concept Videos